DIM (Diindolylmethane) vs Nattokinase

Mechanism

DIM is formed from indole-3-carbinol (I3C, from cruciferous vegetables) via acid condensation in the stomach. It modulates estrogen metabolism by promoting the 2-hydroxylation pathway (producing 2-hydroxyestrone, considered 'protective' estrogen) over the 16alpha-hydroxylation pathway (producing 16alpha-hydroxyestrone, considered proliferative) and the 4-hydroxylation pathway (producing 4-hydroxyestrone, genotoxic). DIM binds the aryl hydrocarbon receptor (AhR), inducing Phase I (CYP1A1, CYP1A2) and Phase II enzymes that facilitate estrogen detoxification. It also inhibits aromatase and has anti-androgen receptor effects (competitive binding).

Standard Dosing

100-200mg DIM daily

Timing

With meals (fat enhances absorption). Consistent daily dosing for estrogen metabolism modulation.

Cycle Duration

ongoing or cycle 8-12 weeks on, 4 weeks off

Side Effects

• Harmless dark-colored urine
• GI upset
• Headache
• Changes in menstrual cycle
• Potential anti-androgenic effects at high doses in men

Contraindications

• Estrogen-dependent conditions where estrogen reduction is not desired
• Concurrent tamoxifen/AI therapy (without oncologist approval)
• Pregnancy/lactation

Best Stacking Partners

Mechanism

Nattokinase is a fibrinolytic serine protease extracted from natto (fermented soybeans). It directly degrades fibrin (the structural protein of blood clots) through four mechanisms: direct fibrinolysis, enhancement of endogenous tPA (tissue plasminogen activator) production, conversion of prourokinase to urokinase, and degradation of PAI-1 (plasminogen activator inhibitor-1). It also reduces blood viscosity and may inhibit ACE (angiotensin-converting enzyme), providing mild antihypertensive effects.

Standard Dosing

2000-4000 FU (fibrinolytic units) daily, equivalent to 100-200mg

Timing

On empty stomach, between meals or before bed. Morning and evening split dosing for 24-hour fibrinolytic coverage.

Cycle Duration

ongoing

Side Effects

• Easy bruising
• Nosebleeds
• GI upset
• Rare: serious bleeding events

Contraindications

• Active bleeding or bleeding disorders
• Scheduled surgery (discontinue 2+ weeks prior)
• Concurrent anticoagulant/antiplatelet therapy
• Hemorrhagic stroke history
• Soy allergy
• Active bleeding
• Bleeding disorders
• Pre-surgery (stop 2 weeks prior)
• Concurrent anticoagulation therapy without physician supervision

Best Stacking Partners